TAKARA HOLDINGS INC.

NEWS RELEASE

This page introduces the press release provided to journalists.

2006

page top

2006.12.19

Takara Bio Grants NEB a license for LA-PCR Technology

2006.12.04

Supply of RetroNectin^® to the Peter MacCallum Cancer Centre in Australia for gene therapy clinical trials of multiple myeloma

2006.09.21

Takara Bio Announces PCR Technologies License Agreement

2006.09.06

Supply of RetroNectin^® to Memorial Sloan Kettering Cancer Center's gene therapy clinical study of chronic lymphocytic leukemia

2006.07.25

Takara Bio (Shiga, Japan) announces that peripheral blood T cells expanded on immobilized RetroNectin® have enhanced cytotoxic activity against tumor cells over T cells expanded by conventional method

2006.07.06

Takara Bio Grants exclusive worldwide (excluding Japan) license to InVivoScribe Technologies to use detection method of FLT3 mutation

2006.05.12

Takara Bio Settles Patent Matter with Stratagene

2006.01.09

US Court of Appeals for Federal Circuit remanded a patent lawsuit
relating to Clontech's Reverse Transcriptase (RT) Product

page top